GlassScriptPhysician profile
Robert M Przynosch
NPI 1568439073
$8,888.91
in general payments reported to CMS, 2019-2025
34 companies · $841 in 2025
The $841 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,455 · 2020: $2,170 · 2021: $472 · 2022: $1,934 · 2023: $1,180 · 2024: $836 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,396.22 | 2020 | |
| Wright Medical Technology, INC. | $1,300.77 | 2019-2020 | |
| Treace Medical Concepts, INC. | $1,187.65 | 2021-2025 | |
| Smith+Nephew, INC. | $1,022.31 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Averitas Pharma INC. | $545.90 | 2023-2025 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $467.48 | 2019-2020 | |
| Horizon Therapeutics Plc | $445.47 | 2020-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $391.23 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $381.18 | 2021-2025 | Affinity, Novachor, Puraply |
| Next Science LLC | $224.08 | 2022-2023 | Surgx, Blastx, Xperience |
| Acera Surgical, INC. | $187.75 | 2021-2023 | Restrata Wound Matrix |
| Nevro Corp. | $159.64 | 2022-2023 | Senza |
| Bioventus LLC | $147.48 | 2024 | Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $118.02 | 2022 | |
| Kerecis Limited | $114.81 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $114.79 | 2020-2023 | |
| Amniox Medical, INC. | $100.00 | 2019 | |
| Stryker Corporation | $81.93 | 2022-2025 | Prostep |
| Depuy Synthes Sales INC. | $80.03 | 2023 | Motoband |
| Biocomposites INC | $67.31 | 2024 | |
| Kci USA, INC. | $51.22 | 2020-2022 | |
| Amgen INC. | $47.69 | 2024 | Krystexxa |
| Medtronic, INC. | $45.92 | 2024-2025 | Intellis Adaptivestim |
| Paragon 28, INC. | $32.34 | 2019-2022 | |
| Tactile Systems Technology INC | $31.98 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Aroa Biosurgery Incorporated | $27.53 | 2020 | |
| Linvatec Corporation | $19.60 | 2023 | Biobrace 23mm, Allograft Tissue, Hall Power |
| Zimmer Biomet Holdings, INC. | $15.91 | 2021 | |
| Melinta Therapeutics, LLC | $15.42 | 2019 | |
| Hartmann USA, INC. | $15.38 | 2020 | |
| Mimedx Group, INC. | $14.28 | 2025 | |
| Orthofix Medical, INC. | $13.90 | 2024 | Accelstim, Physio-Stim |
| Solventum Corporation | $13.19 | 2024 | Activ.A.C. |
| Boston Scientific Corporation | $10.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Przynosch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.